Article Page

Abstract

This paper discusses quantum mechanical schemas for describing waves with non-abelian phases, Fock spaces of annihilation-creation operators for these structures, and the Feynman recipe for obtaining descriptions of particle interactions with external fields applied to predicted chemo-polypharmacophoric agent on Hypercomplex Extensions of a Quantum Theory Bayesian parameter estimation for nonlinear modelling of biological pathways comprising (Propeptide-Fc)/MGF peptide mimicking high free binding energy properties towards Wnt7a/Fzd7 signalling Akt/mTOR anabolic growth IGF-I/PI3K/Akt -I/MAPK/ERK pathways.

Keywords

Hypercomplex Extensions; Quantum Theory; Bayesian parameter estimation; nonlinear modelling; biological pathways; chemo-polypharmacophoric agent; (Propeptide-Fc)/MGF; peptide mimicking; high free binding energy; properties towards Wnt7a/Fzd7 signalling; Akt/mTOR anabolic growth; IGF-I/PI3K/Akt -I/MAPK/ERK pathways; Composition Algebras, Hilbert Spaces, Fock Spaces, Non-Abelian Gauge Fields

Article Type

Research Article - Abstract

Publication history

Received: Sep 20, 2017 Accepted: Sep 25, 2017 Published: Oct 01, 2017

Citation

Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) A predicted chemo-polypharmacophoric agent on Hypercomplex Extensions of a Quantum Theory Bayesian parameter estimation for nonlinear modelling of biological pathways comprising (Propeptide-Fc)/MGF peptide mimicking high free binding energy properties towards Wnt7a/Fzd7 signalling Akt/mTOR anabolic growth IGF-I/PI3K/Akt -I/MAPK/ERK pathways.

Authors Info

Grigoriadis Nikolaos Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM, Biogenea Pharmaceuticals Ltd, Thessaloniki, Greece;

Grigoriadis Ioannis Department of Computer Drug Discovery Science, BiogenetoligandorolTM, Biogenea Pharmaceuticals Ltd, Thessaloniki, Greece;

Grigoriadis George Department of Stem Cell Bank and ViroGeneaTM, Biogenea Pharmaceuticals Ltd, Thessaloniki, Greece;

George Galazios Professor of Obstetrics and Gynecology, Democritus University of Thrace, Komotini, Greece;

E-mail: biogeneadrug@gmail.com